摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(p-cyclopentyl)phenoxyprop-1-ene | 88737-65-9

中文名称
——
中文别名
——
英文名称
3-(p-cyclopentyl)phenoxyprop-1-ene
英文别名
1-Cyclopentyl-4-[(prop-2-en-1-yl)oxy]benzene;1-cyclopentyl-4-prop-2-enoxybenzene
3-(p-cyclopentyl)phenoxyprop-1-ene化学式
CAS
88737-65-9
化学式
C14H18O
mdl
——
分子量
202.296
InChiKey
OXNCFMNNGORTPD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:a7a84b3578e6608556e7d96ae9c8ecf3
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(p-cyclopentyl)phenoxyprop-1-ene 在 palladium on activated charcoal 氢气potassium carbonate 作用下, 以 甲醇N,N-二甲基甲酰胺邻二氯苯 为溶剂, 生成
    参考文献:
    名称:
    Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists
    摘要:
    A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling. (C) 2003 Published by Elsevier Ltd.
    DOI:
    10.1016/s0960-894x(03)00785-6
  • 作为产物:
    描述:
    参考文献:
    名称:
    Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists
    摘要:
    A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling. (C) 2003 Published by Elsevier Ltd.
    DOI:
    10.1016/s0960-894x(03)00785-6
点击查看最新优质反应信息

文献信息

  • Kumar, Surat; Rastogi, Shri Nivas, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1983, vol. 22, # 7, p. 659 - 663
    作者:Kumar, Surat、Rastogi, Shri Nivas
    DOI:——
    日期:——
  • KUMAR, SURAT;RASTOGI, SRI, NIVAS, INDIAN J. CHEM., 1983, 22, N 7, 59-663
    作者:KUMAR, SURAT、RASTOGI, SRI, NIVAS
    DOI:——
    日期:——
  • Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists
    作者:Ranjit C. Desai、Dominick F. Gratale、Wei Han、Hiroo Koyama、Edward Metzger、Victoria K. Lombardo、Karen L. MacNaul、Thomas W. Doebber、Joel P. Berger、Kwan Leung、Ronald Franklin、David E. Moller、James V. Heck、Soumya P. Sahoo
    DOI:10.1016/s0960-894x(03)00785-6
    日期:2003.10
    A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling. (C) 2003 Published by Elsevier Ltd.
查看更多